Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» MannKind: Afrezza's slow start due to delays not demand for inhalable insulin
MannKind: Afrezza's slow start due to delays not demand for inhalable insulin
MannKind: Afrezza's slow start due to delays not demand for inhalable insulin
Submitted by
admin
on May 17, 2015 - 1:33pm
Source:
In-Pharma Technologist
News Tags:
MannKind
Afrezza
diabetes
insulin
inhaled insulin
Sanofi
Headline:
MannKind: Afrezza's slow start due to delays not demand for inhalable insulin
Do Not Allow Advertisers to Use My Personal information
